(R)-Hexahydropyrrolo[1,2-a]pyrazine-1,4-dione, 95.0%, 1g

4-Methoxy-2-(trifluoromethyl)phenylboronic acid, 95.0%, 1g

5-Bromo-1,2-dimethyl-3-(trifluoromethyl)benzene, 95+%, 250mg

Methyl 2-amino-2-(tetrahydro-2H-pyran-4-yl)acetate, 95.0%, 1g

3-{4-chloro-5,6-dimethylthieno[2,3-d]pyrimidin-2-yl}pyridine, 97%, 250mg

(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoate, 97.0%, 250mg

Analytical and precision scale Entris® II series Models with internal adjustment, not certified, 0.01 g, 3200 g, BCE3202i-1S

Methyl 3-oxo-1,2,3,4-tetrahydroisoquinoline-7-carboxylate, 95%, 250mg

4-(4-Methylphenyl)-4-oxobutyric Acid>98.0%(GC)(T)25g

N,N'-Di-1-naphthyl-N,N'-diphenylbenzidine (purified by sublimation)>99.0%(HPLC)(N)1g

4'-Fluoro-2'-nitroacetanilide>98.0%(GC)25g

2-(1H-IMIDAZOL-1-YL)-N-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ACETAMIDE, 95%, 1g

1(2H)-PYRIDINECARBOXYLIC ACID, 3,6-DIHYDRO-4-METHYL-, 1,1-DIMETHYLETHYL ESTER, 95.0%, 100mg